Cubist Systematic Strategies, LLC Immatics N.V. Transaction History
Cubist Systematic Strategies, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 35,394 shares of IMTX stock, worth $301,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,394
Previous 206,920
82.89%
Holding current value
$301,910
Previous $2.4 Million
83.24%
% of portfolio
0.0%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
75.6MCall Options Held
185KPut Options Held
611K-
Rtw Investments, LP New York, NY10MShares$85.3 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$82.6 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$69 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$62.9 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$55 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $650M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...